Puff Puff Post

JANUARY 24, 2019

which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. Companies have also been anticipating the legalization of recreational weed since the Liberal government came to power in 2015.

Research and Development 111

Research and Development Legalization Marijuana Recreational 111

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”. Taking CBD can relieve pain.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

JUNE 11, 2019

Poirier sued following a surgical procedure that left her with chronic pain and limitations affecting her lifestyle and career. He had a history of drug use both before and after the accidents that included cocaine, heroin, and crystal meth. Gordon had a significant history of drug use. Robichaud 4. ” 42.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

JULY 24, 2022

analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. Of particular note are conditions such as cancer and multiple sclerosis, where cannabis-based medicines can alleviate chronic pain. In this documentary series, author Michael Pollan and Co.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. It also has an extensive and diverse history of medicinal use. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

Cannabis use, both medically and recreationally, is prevalent throughout history. 7 While the lifetime use remains relatively stable for this cohort, from 2015-2017, past year and past month use increased 2.7% In 2015, Whiting, et al, performed a meta-analysis and systematic review of research on the medical use of cannabis.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Greencamp

DECEMBER 4, 2018

This reaction is dependent on the type of cell that was activated through these receptors, but also on the condition our body is struggling with. The way a specific cell reacts when a cannabinoid activates its receptor is also dependent on the type of condition that an organism is afflicted with. Chronic Pain. Depression.

Cannabinoids 107

Cannabinoids Research and Development Conditions THC 107

Green Relief

MAY 13, 2018

These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. Reference [link].

THC 64

THC CBD Cannabinoids Research and Development 64

StrainConnect

FEBRUARY 8, 2019

A 2015 Israeli study found that full-spectrum CBD oil is effective at much lower doses and has a wider therapeutic window than a CBD isolate(17). However, a 2015 study at the Hebrew University of Jerusalem’s Lautenberg Center for General and Tumor Immunology discovered the Entourage Effect(21). 2015, Feb.). 2015, Jan.).

Hemp 57

Hemp CBD Cannabinoids Sativa 57